Funding Status: Late Stage Venture
Industry: End-to-End Drug Development
Investors Number: 18.0
Last Funding Date: 2021-09-24
Technology: Biotechnology, Health Care
Founded Date: 2015-01-01
Headquarters: Vancouver, British Columbia, Canada
Total Funding: 204000000.0
Last Funding Type: Series D
Employee Number: 11-50